BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers-Reference-Cited by-同舟云学术

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Published:2017-08-22 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Maxwell Kara N.,Wubbenhorst Bradley,Wenz Brandon M.,De Sloover Daniel,Pluta John,Emery Lyndsey,Barrett Amanda,Kraya Adam A.,Anastopoulos Ioannis N.,Yu Shun,Jiang Yuchao,Chen Hao,Zhang Nancy R.,Hackman Nicole,D’Andrea Kurt,Daber Robert,Morrissette Jennifer J. D.,Mitra Nandita,Feldman Michael,Domchek Susan M.,Nathanson Katherine L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-00388-9.pdf

Reference70 articles.

1. Daly, M. B. et al. Genetic/familial high-risk assessment: breast and ovarian. J. Natl Compr. Cancer Netw. 8, 562–594 (2010).

2. Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130 (2003).

3. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J. Natl Cancer. Inst. 91, 1310–1316 (1999).

4. Turner, N., Tutt, A. & Ashworth, A. Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer. 4, 814–819 (2004).

5. Kamieniak, M. M. et al. DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas. Br. J. Cancer 108, 1732–1742 (2013).

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset;The American Journal of Human Genetics;2024-09

2. Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors;Genome Medicine;2024-08-28

3. Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers;Antioxidants;2024-07-14

4. Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status;Breast Cancer;2024-06-13

5. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma;Clinical Cancer Research;2024-06-05